Clinical trials
Phase 2 Heart Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardurion Pharmaceuticals, Inc. | 3 |
| Abcentra | 1 |
| Bayer | 1 |
| Celladon Corporation | 1 |
| Gilead Sciences | 1 |
| Kiniksa Pharmaceuticals International, plc | 1 |
| Sanofi | 1 |
| University of East Anglia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 10 |
| Cardiovascular Diseases | 4 |
| Heart Failure | 4 |
| Cardiomyopathies | 2 |
| Coronary Artery Disease | 2 |
| Acute Coronary Syndrome | 1 |
| Adenoviridae Infections | 1 |
| Atherosclerosis | 1 |
| Cardiomegaly | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.